JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M000506200 on March 19, 2000

J. Biol. Chem., Vol. 275, Issue 21, 16084-16090, May 26, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/21/16084    most recent
M000506200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joseph, S. K.
Right arrow Articles by Zeigler, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joseph, S. K.
Right arrow Articles by Zeigler, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Factors Determining the Composition of Inositol Trisphosphate Receptor Hetero-oligomers Expressed in COS Cells*

Suresh K. JosephDagger , Shaila Bokkala, Darren Boehning, and Samuel Zeigler

From the Department of Pathology and Cell Biology, Thomas Jefferson University School of Medicine, Philadelphia, Pennsylvania 19107

COS-7 cells were transiently transfected with type I and type III myo-inositol 1,4,5-trisphosphate receptor (IP3R) isoforms to study the processes underlying assembly and oligomerization of these tetrameric proteins. A FLAG epitope was engineered on to the N terminus of the type III IP3R to distinguish the transfected from the endogenous isoform. This was not necessary for the type I IP3R, since the endogenous levels of this isoform were extremely low. Based on sucrose gradient analysis, the transfected type I or FLAG-type III IP3Rs assembled into tetramers. Confocal immunofluorescence experiments confirmed that the constructs were primarily targeted to the endoplasmic reticulum. Recombinant type I IP3R expressed in COS cells over a 48-h period showed a negligible capacity to form hetero-oligomers with endogenous type III IP3Rs, based upon co-immunoprecipitation assays. However, substantial formation of hetero-oligomers was observed between recombinant receptors when the cells were simultaneously transfected with type I and FLAG-type III IP3Rs. Co-immunoprecipitation experiments using lysates from metabolically labeled cells allowed the quantitation of homo- and hetero-oligomers in cells transfected with different ratios of type I and FLAG-type III IP3R DNA. These studies show that the relative expression level of the two isoforms influences the fraction of hetero-oligomers formed. However, the proportion of hetero-oligomers formed were less than predicted by a binomial model in which the association of subunits is assumed to be random. In doubly transfected cells, the early kinetics of 35S label incorporation into homotetramers showed a lag period corresponding to the time taken to synthesize a full-length receptor. However, hetero-oligomers were synthesized with a longer lag period, suggesting that there may be kinetic constraints that favor homo-oligomers over hetero-oligomers.


* This work was supported by National Institutes of Health Grants T32-AA07463 (to S. B and D. B.), RO1-GM58574, and R01-AA10971.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Pathology and Cell Biology, Thomas Jefferson University, Rm. 230A JAH, 1020 Locust St., Philadelphia, PA 19107. Tel.: 215-503-1221; Fax: 215-923-6813; E-mail: Suresh.Joseph@mail.tju.edu.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. S. Park, M. J. Betzenhauser, J. H. Won, J. Chen, and D. I. Yule
The Type 2 Inositol (1,4,5)-Trisphosphate (InsP3) Receptor Determines the Sensitivity of InsP3-induced Ca2+ Release to ATP in Pancreatic Acinar Cells
J. Biol. Chem., September 19, 2008; 283(38): 26081 - 26088.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. E. Wagner II, S. K. Joseph, and D. I. Yule
Regulation of single inositol 1,4,5-trisphosphate receptor channel activity by protein kinase A phosphorylation
J. Physiol., August 1, 2008; 586(15): 3577 - 3596.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. K. Foskett, C. White, K.-H. Cheung, and D.-O. D. Mak
Inositol Trisphosphate Receptor Ca2+ Release Channels
Physiol Rev, April 1, 2007; 87(2): 593 - 658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. B. van Rossum, R. L. Patterson, K.-H. Cheung, R. K. Barrow, V. Syrovatkina, G. S. Gessell, S. G. Burkholder, D. N. Watkins, J. K. Foskett, and S. H. Snyder
DANGER, a Novel Regulatory Protein of Inositol 1,4,5-Trisphosphate-Receptor Activity
J. Biol. Chem., December 1, 2006; 281(48): 37111 - 37116.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ferreri-Jacobia, D.-O. D. Mak, and J. K. Foskett
Translational Mobility of the Type 3 Inositol 1,4,5-Trisphosphate Receptor Ca2+ Release Channel in Endoplasmic Reticulum Membrane
J. Biol. Chem., February 4, 2005; 280(5): 3824 - 3831.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Ando, A. Mizutani, T. Matsu-ura, and K. Mikoshiba
IRBIT, a Novel Inositol 1,4,5-Trisphosphate (IP3) Receptor-binding Protein, Is Released from the IP3 Receptor upon IP3 Binding to the Receptor
J. Biol. Chem., March 14, 2003; 278(12): 10602 - 10612.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. H. Wojcikiewicz, Q. Xu, J. M. Webster, K. Alzayady, and C. Gao
Ubiquitination and Proteasomal Degradation of Endogenous and Exogenous Inositol 1,4,5-Trisphosphate Receptors in alpha T3-1 Anterior Pituitary Cells
J. Biol. Chem., January 3, 2003; 278(2): 940 - 947.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. L. Galvan and G. A. Mignery
Carboxyl-terminal Sequences Critical for Inositol 1,4,5-Trisphosphate Receptor Subunit Assembly
J. Biol. Chem., December 6, 2002; 277(50): 48248 - 48260.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Yang, S. McBride, D.-O. D. Mak, N. Vardi, K. Palczewski, F. Haeseleer, and J. K. Foskett
From the Cover: Identification of a family of calcium sensors as protein ligands of inositol trisphosphate receptor Ca2+ release channels
PNAS, May 28, 2002; 99(11): 7711 - 7716.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Boehning and S. K. Joseph
Functional Properties of Recombinant Type I and Type III Inositol 1,4,5-Trisphosphate Receptor Isoforms Expressed in COS-7 Cells
J. Biol. Chem., July 7, 2000; 275(28): 21492 - 21499.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.